Regulation of Human Affective Responses by Anterior Cingulate and Limbic μ-Opioid Neurotransmission

Archives of General Psychiatry

Volumn 60, Issue 11, 2003, Pages 1145-1153

  Zubieta, Jon Kar ^a,b   Ketter, Terence A ^c   Bueller, Joshua A ^a   Xu, Yanjun ^a   Kilbourn, Michael R ^b   Young, Elizabeth A ^a   Koeppe, Robert A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CARFENTANIL; METHYL IODIDE; MU OPIATE RECEPTOR; NEUROTRANSMITTER; TRACER;

ADULT; AFFECT; AMYGDALOID NUCLEUS; ARTICLE; ASSOCIATION; BRAIN REGION; CINGULATE GYRUS; COMPUTER SIMULATION; CONTROLLED STUDY; EMOTION; EXPERIENCE; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGING; ISOTOPE LABELING; LIFE EVENT; LIMBIC CORTEX; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; RANDOMIZATION; RATING SCALE; RECALL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; SADNESS; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX; UNIVERSITY HOSPITAL; VOLUNTEER;

ADULT; AFFECT; ANALGESICS, OPIOID; BRAIN MAPPING; CARBON RADIOISOTOPES; FEMALE; FENTANYL; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIMBIC SYSTEM; NERVE NET; RECEPTORS, OPIOID, MU; SUBTRACTION TECHNIQUE; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0242678438     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.11.1145     Document Type: Article

References (75)

1. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM. Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry. 1995;152:341-351.
2. Adolphs R, Damasio H, Tranel D, Damasio A. Cortical systems for the recognition of emotion in facial expressions. J Neurosci. 1996;16:7678-7687.
3. Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL, Strauss MM, Hyman SE, Rosen BR. Response and habituation of the human amygdala during visual processing of facial expression. Neuron. 1996;17:875-887.
4. Morris JS, Friston KJ, Buchel C, Frith CD, Young AW, Calder AJ, Dolan RJ. A neuromodulatory role for the human amygdala in processing emotional facial expressions. Brain. 1998;121:47-57.
5. Taylor S, Liberzon I, Fig L, Decker L, Minoshima S, Koeppe R. The effect of emotional content on visual recognition memory: a PET activation study. Neuroimage. 1998;8:188-197.
6. Davidson R, Irwin W. The functional neuroanatomy of emotion and affective style. Trends Cogn Sci. 1999;3:11-21.
7. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL, Fox PT. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675-682.
8. Calder A, Lawrence A, Young A. Neuropsychology of fear and loathing. Nat Rev Neurosci. 2001;2:352-363.
9. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 1995;25:247-261.
10. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 1996;93:3908-3913.
11. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824-827.
12. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997;9:471-481.
13. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab. 2000;20:423-451.
14. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science. 2001;293:311-315.
15. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS. Mu-opioid receptor-mediated antinociception differs in men and women. J Neurosci. 2002;22:5100-5107.
16. Mansour A, Fox C, Akil H, Watson S. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995;18:22-29.
17. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain. 1995;118:279-306.
18. Vogt B, Wiley R, Jensen E. Localization of mu and delta opioid receptors to anterior cingulate afferents and projection neurons and input/output model of Mu regulation. Exp Neurol. 1995;135:83-92.
19. Marek G, Aghajanian G. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation. Neuroscience. 1998;86:485-497.
20. McGaugh JL. Neuroscience-memory: a century of consolidation. Science. 2000;287:248-251.
21. Mogenson G, Yang C. The contribution of the basal forebrain to limbic-motor integration and the mediation of motivation to action. In: Napier T, Kalivas P, Hanin I, eds. The Basal Forebrain: Anatomy to Function, New York, NY: Plenum Press; 1991:267-290.
22. Steiner H, Gerfen CR. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res. 1998;123:60-76.
23. Napier T, Mitrovic I. Opioid modulation of ventral pallidal inputs. Ann N Y Acad Sci. 1999;877:176-201.
24. Akil H, Watson S, Young E, Lewis M, Khachaturian H, Walker J. Endogenous opioids: biology and function. Annu Rev Neurosci. 1984;7:223-255.
25. Kalin N, Shelton S. Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation. Science. 1989;243:1718-1721.
26. Kalin N, Shelton S, Barksdale C. Opiate modulation of separation-induced distress in non-human primates. Brain Res. 1988;440:285-292.
27. Good A, Westbrook R. Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Behav Neurosci. 1995;109:631-641.
28. Quirarte G, Galvez R, Roozendaal B, McGaugh J. Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 1998;808:134-140.
29. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet. 2000;25:195-200.
30. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240-1243.
31. George MS, Ketter TA, Parekh PI, Herscovitch P, Post RM. Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry. 1996;40:859-871.
32. Cahill L, Haier RJ, White NS, Fallon J, Kilpatrick L, Lawrence C, Potkin SG, Alkire MT. Sex-related difference in amygdala activity during emotionally influenced memory storage. Neurobiol Learn Mem. 2001;75:1-9.
33. Gross-Isseroff R, Dillon K, Israeli M, Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 1990;530:312-316.
34. Gabilondo A, Meana J, Garcia-Sevilla J. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res. 1995;682:245-250.
35. Zubieta J, Dannals R, Frost J. Gender and age influences on human brain mu opioid receptor binding measured by PET. Am J Psychiatry. 1999;156:842-848.
36. Titeler M, Lyon RA, Kuhar MJ, Frost JF, Dannals RF, Leonhardt S, Bullock A, Rydelek LT, Price DL, Struble RG. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. Eur J Pharmacol. 1989;167:221-228.
37. Sastre M, Garcia-Sevilla J. Density of alpha-2A adrenoceptors and Gi proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age. J Pharmacol Exp Ther. 1994;269:1062-1072.
38. Kenakin T. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. Trends Pharmacol Sci. 1997;18:456-464.
39. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometric Research Department New York Psychiatric Institute; 1995.
40. Smith YR, Zubieta JK, del Carmen MG, Dannals RF, Ravert HT, Zacur HA, Frost JJ. Brain mu opioid receptor measurements by positron emission tomography in normal cycling women: relationship to LH pulsatility and gonadal steroid hormones. J Clin Endocrinol Metab. 1998;83:4498-4505.
41. 11C]carfentanil. Int J Appl Radiat Isot. 1985;36:303-306.
42. 11C]carfentanil. Nucl Med Biol. 2001;28:733-734.
43. Minoshima S, Koeppe RA, Mintun MA, Berger KL, Taylor SF, Frey KA, Kuhl DE. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med. 1993;34:322-329.
44. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
45. Meyer CR, Boes JL, Kim B, Bland PH, Zasadny KR, Kison PV, Koral K, Frey KA, Wahl RL. Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal. 1997;1:195-206.
46. Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063-1070.
47. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RS. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp. 1995;2:189-210.
48. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab. 1992;12:900-918.
49. Lane R, Reiman E, Ahern G, Schwartz G, Davidson R. Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry. 1997;154:926-933.
50. Damasio AR, Grabowski TJ, Bechara A, Damasio H, Ponto LL, Parvizi J, Hichwa RD. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nature Neurosci. 2000;3:1049-1056.
51. Ketter T, Wang P, Lembke A, Sachs N. Physiological and pharmacological induction of affect. In: Davidson R, Scherer K, Goldsmith H, eds. The Handbook of Affective Science. New York, NY: Oxford University Press; 2002:930-962.
52. Ketter TA, Wang PW, Sachs N, Jimison JJ, Segall GM. Commonalities and Dissociations in Anterior Paralimbic Metabolic Decreases With Sustained Sadness in Female Unipolar Depressives Versus Bipolar II Depressives and Healthy Volunteers. San Juan, Puerto Rico: American College of Neuropsychopharmacology; 2002:147.
53. Taylor S, Liberzon I, Koeppe R. The effect of graded aversive stimuli on limbic and visual activation. Neuropsychologia. 2000;38:1415-1425.
54. Rainville P, Duncan G, Price D, Carrier B, Bushnell M. Pain affect encoded in human anterior cingulate but not somatosensory, cortex. Science. 1997;277:968-971.
55. Tolle TR, Kaufmann T, Siessmeier T, Lautenbacher S, Berthele A, Munz F, Zieglgansberger W, Willoch F, Schwaiger M, Conrad B, Bartenstein P. Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol. 1999;45:40-47.
56. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48:830-843.
57. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997;8:1057-1061.
58. Kalivas P, Churchill L, Romanides A. Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci. 1999;877:64-70.
59. Austin M, Kalivas P. Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Brain Res. 1991;542:123-131.
60. Chrobak J, Napier T. Opioid and GABA modulation of accumbens-evoked ventral pallidal activity. J Neural Transm Gen Sect. 1993;93:123-143.
61. Johnson P, Napier T. Morphine modulation of GABA- and glutamate-induced changes of ventral pallidal neuronal activity. Neuroscience. 1997;77:187-197.
62. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16:331-348.
63. Liberzon I, Zubieta JK, Fig LM, Phan KL, Koeppe RA, Taylor SF. mu-Opioid receptors and limbic responses to aversive emotional stimuli. Proc Natl Acad Sci U S A. 2002;99:7084-7089.
64. Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ, Yun LS, Chen K. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry. 1997;154:918-925.
65. Davidson R, Putnam K, Larson C. Dysfunction in the neural circuitry of emotion regulation: a possible prelude to violence. Science. 2000;289:591-594.
66. Watkins L, Mayer D. Organization of endogenous opiate and nonopiate pain control systems. Science. 1982;216:1185-1192.
67. Rubinstein M, Mogil JS, Japon M, Chan EC, Allen RG, Low MJ. Absence of opioid stress-induced analgesia in mice lacking B-endorphin by site directed mutagenesis. Proc NatlAcad Sci U S A. 1996;93:3995-4000.
68. La Buda C, Sora I, Uhl G, Fuchs P. Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system. Brain Res. 2000;869:1-5.
69. Curtis AL, Bello NT, Valentino RJ. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J Neurosci. 2001;21:RC152.
70. Wand GS, McCaul M, Yang X, Reynolds J, Gotjen D, Lee S, Ali A. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 2002;26:106-114.
71. Gear R, Levine J. Antinociception produced by an ascending spino-supraspinal pathway. J Neurosci. 1995;15:3154-3161.
72. Kraus M, Piper J, Kornetsky C. Naloxone alters the local metabolic rate for glucose in discrete bran regions associated with opiate withdrawal. Brain Res. 1996;724:33-40.
73. Gestreau C, Le GS, Besson J. Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide. J Comp Neurol. 2000;427:285-301.
74. Kessler R. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48:191-214.
75. Enoch MA, Xu K, Ferro E, Harris C, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet. 2003;13:33-41.